Integra Lifesciences Holdings (IART) Work In Process (2010 - 2017)

Integra Lifesciences Holdings (IART) reported Work In Process of $47.3 million for Q3 2017, down 5.57% sequentially from $50.0 million in Q4 2016.

Integra Lifesciences Holdings (IART) Work In Process (2010 - 2017) Analysis & Trends

Integra Lifesciences Holdings (IART) has 7 years of Work In Process data on file, last reported at $47.3 million in Q3 2017.

For the quarter ending Q3 2017, Work In Process changed N/A year-over-year to $47.3 million; the trailing twelve-month figure through Sep 2017 stood at $47.3 million (changed N/A YoY), and the FY2016 full-year result was $50.0 million, changed N/A from the prior year.
Work In Process eased to $47.3 million in Q3 2017, from $50.0 million in the prior quarter.
In the past five years, Work In Process ranged from a high of $54.7 million in Q2 2015 to a low of $47.3 million in Q3 2017.
A 4-year average of $50.5 million and a median of $50.1 million in 2014 frame the typical range for Work In Process.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Integra Lifesciences Holdings	1.71 Bn	1.45 Bn	216.98 Mn

Download Data